4
Changes in Ownership
RESMED INC Filed Acc 0001127602-25-011839
Chief Executive Officer sold 8,009 shares at $209.85 ($1,680,699)
- Chief Executive Officer acquired 8,009 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Farrell Michael J. · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-04-07 | Exercise or conversion : show line 1 in the form 10b5-1 | +8,009 | $101.64 | $814,035 | 463,482 | D |
| 2025-04-07 | Sale : show line 2 in the form 10b5-1 | −8,009 | $209.85 | $1,680,699 | 455,472 | D |
| Open-market sales · 8,009 sh · avg $209.85 · $1,680,699 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-04-07 | Exercise or conversion : show line 3 in the form 10b5-1 ResMed Common Stock Options | −8,009 | 56,065 | D |
Loading xslF345X05/form4.xml…